Home › ALS at Motor Neuron Disease › Maryland
Pag-aaral pangklinika para sa ALS at Motor Neuron Disease sa Maryland
7 pag-aaral para sa ALS at Motor Neuron Disease ang naghahanap ng mga kalahok sa mga site sa Maryland.
Opisyal na teksto ng pag-aaral (English)
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07204977Study of Inherited Neurological Disorders
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00004568Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 110 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01900132Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT03225144Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Kalalakihan · Na-update Ago 13, 2026 · NCT04944940Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth
- TidalHealth Peninsula Regional, Inc., Salisbury
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT07491484Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Johns Hopkins Medicine Brain Science Institute, Baltimore
Nagre-recruitPhase 3
Edad 18 hanggang 81 · Lahat ng kasarian · Na-update Set 12, 2025 · NCT03127267Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.